News und Analysen
Dixon Mitchell Investment Counsel Buys the Dip: Adds $23 Million of Descartes Systems
On Nov. 13, 2025, Dixon Mitchell Investment Counsel Inc. disclosed a buy of 255,154 shares in The Descartes Systems Group (NASDAQ:DSGX), increasing its stake by an estimated $23.42 million.
Durable Capital Liquidates Descartes Systems Position: Should Investors Avoid the Stock?
Durable Capital Partners LP fully exited its position in The Descartes Systems Group (NASDAQ:DSGX), cutting 2,253,704 shares, for an estimated $229.08 million portfolio shift, according to a Nov
Descartes Stock Down 29% in a Year — Is That Why a Major Investor Just Cut Its Stake?
New York City-based Praesidium Investment Management Company cut its stake in The Descartes Systems Group (NASDAQ:DSGX) by 206,057 shares in the third quarter, according to a November 14 SEC filing.
Cartesian (RNAC) Q2 Revenue Drops 99%
Cartesian Therapeutics (NASDAQ:RNAC), a biotechnology company pioneering mRNA cell therapies for autoimmune diseases, The company released its Q2 2025 earnings on August 7, 2025. In the update, the